References
- Fratantoni J. C. Points to consider in the safety evaluation of hemoglobin based oxygen carriers. Transfusion 1991; 31(4)369–371
- Chang T. M.S., Lister C. A screening test of modified hemoglobin blood substitute before clinical use in patients-based on complement activation of human plasma. Int. J. Biomaterials, Artificial Cells and Artificial Organs 1990; 18(5)693–702
- Chang T. M.S., Lister C. A preclinical screening test for modified hemoglobin to bridge the gap between animal safety studies and use in human. Biomaterials, Artificial Cells and Immobilization Biotechnology 1992; 20(2-4)565–573
- Chang T. M.S., Lister C. An in-vitro method to determine the safety of modified hemoglobin blood substitute for human prior to clinical use. US patent April, 1993; 5: 323, 200, 1993
- Ning J., Chang T.M.S. Effects of stroma-free hemoglobin and polyhemoglobin on blood cells, complement activation and coagulation factors in rats (abs). J. Biomaterials, Artificial Cells and Artificial Organs 1987; 15: 380
- Ning J., Chang T.M.S. Effects of stroma-free hemoglobin and polyhemoglobin on blood cells, complement activation and coagulation factors in rats. J. Biomaterials, Artificial Cells and Artificial Organs 1988; 16: 651–652
- Feola M., Simoni J., Canizaro P. C. Complement activation and the toxicity of stroma-free hemoglobin solution in primates. Cir. Shock 1988; 25: 275–290
- Chang T. M.S., Yu W. P. Biodegradable polymer membrane containing hemoglobin for blood substitute. British Provisional Patent Application September 14, 1992, 1992 U.K. number 9219426.5
- Yu W. P., Chang T.M.S. Submicron biodegradable polymer encapsulated hemoglobin as potential red blood substitutes. V International Symposium on Blood Substitutes, San Diego 1993, Abstract
- Deane N., Wineman R. J. Multiple use of hemodialysers. Replacement of Renal Function by Dialysis, J.F. Maher. Kluwer Academic Publisher, Boston 1988; 401–416
- Chang T. M.S., Lister C., Wong L. T., Er S. S. The use of a preclinical screening test based on C3a activation of human plasma in industrial production of o-raffinose polymerized hemoglobin. V International Symposium on Blood Substitutes, San Diego 1993, Abstract
- Chang TMS, Lister CW. Use of finger-prick human blood samples as a more convenient way for in vitro screening of modified hemoglobin blood substitutes for complement activation. J. Biomaterials, Artificial Cells and Immobilization Biotechnology 1993; 21: 685–690